Page last updated: 2024-10-29

ketanserin and Tachycardia, Supraventricular

ketanserin has been researched along with Tachycardia, Supraventricular in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Tachycardia, Supraventricular: A generic expression for any tachycardia that originates above the BUNDLE OF HIS.

Research Excerpts

ExcerptRelevanceReference
"A patient is reported who developed a marked prolongation of QTc and life threatening ventricular arrhythmias during oral Ketanserin therapy."7.67Ventricular arrhythmias and QT-prolongation during therapy with ketanserin: report of a case. ( De Geest, H; Vandermotten, M; Verhaeghe, R, 1989)
"A patient is reported who developed a marked prolongation of QTc and life threatening ventricular arrhythmias during oral Ketanserin therapy."3.67Ventricular arrhythmias and QT-prolongation during therapy with ketanserin: report of a case. ( De Geest, H; Vandermotten, M; Verhaeghe, R, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vandermotten, M1
Verhaeghe, R1
De Geest, H1

Other Studies

1 other study available for ketanserin and Tachycardia, Supraventricular

ArticleYear
Ventricular arrhythmias and QT-prolongation during therapy with ketanserin: report of a case.
    Acta cardiologica, 1989, Volume: 44, Issue:5

    Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Electrocardiography; Humans; Ketanserin; Long QT S

1989